4978

ReproCELL Incorporated

株式会社リプロセル
Healthcare · Biotechnology
ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-derived exosomes. The company also provides Alvetex 3D, a cell culture system; Alvetex, an advanced tissue bioengineering system; EZSPHERE Multiwell Dishes and Plates; KOKEN atelocollagen; ABLE Biott bioreactor systems; and 2mag stirrer systems. In addition, It offers research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
← Companies
Price
¥129
Market Cap
¥12.2B
Ent. Value
Net Cash est
Shares Out.
94.7M
P / E
116.2×
EV / EBIT
P / Book
1.36×
P / NCAV
2.90×
Div. Yield
Financials
Metric FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥3.0B ¥2.4B ¥3.0B ¥2.2B
Cost of Sales ¥1.3B ¥1.3B ¥1.8B ¥1.4B
Gross Profit ¥1.6B ¥1.1B ¥1.1B ¥803M
SG&A ¥1.8B ¥1.5B ¥1.5B ¥1.5B
Operating Income ¥-130M ¥-409M ¥-356M ¥-647M
Non-Operating Income ¥202M ¥459M ¥242M ¥206M
Interest Income ¥67M ¥51M ¥43M ¥9M
Non-Operating Expenses ¥27M ¥9M ¥6M ¥66M
Interest Expense ¥0M ¥0M
Ordinary Income ¥45M ¥40M ¥-120M ¥-507M
Pre-tax Income ¥45M ¥-29M ¥-304M ¥-574M
Income Taxes ¥-58M ¥3M ¥2M ¥1M
Current Tax ¥-2M ¥3M ¥2M ¥2M
Deferred Tax ¥-57M ¥-0M ¥-0M ¥-0M
Net Income (owners) ¥103M ¥-31M ¥-305M ¥-575M
Minority Interest ¥-0M
Comprehensive Income ¥-57M ¥136M ¥-287M ¥-568M
EBITDA ¥-80M ¥-372M ¥-307M ¥-587M
Goodwill Amort. (J-GAAP) ¥3M ¥3M ¥3M ¥3M
EPS ¥1.11 ¥-0.37 ¥-3.62 ¥-7.57
Shares Outstanding 94.7M 88.9M 85.1M 82.2M
Shares Issued (total) 94.8M 89.0M 85.1M 82.3M
Treasury Shares 0.1M 0.1M 0.0M 0.0M